Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hassan, I. A.
Right arrow Articles by Johnson, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hassan, I. A.
Right arrow Articles by Johnson, A. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2001) 48, 454-455
© 2001 The British Society for Antimicrobial Chemotherapy


Correspondence

Clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to teicoplanin in Northwest England

Ibrahim A. Hassana,*, Paul R. Chadwicka and Alan P. Johnsonb

a Microbiology Department, Salford Royal Hospitals NHS Trust, Hope Hospital, Salford M6 8HD; b Antibiotic Resistance Monitoring and Reference Laboratory, Central Public Health Laboratory, Colindale, London NW9 5HT, UK

Sir,

We describe two cases of post-operative wound infection caused by methicillin-resistant Staphylococcus aureus (MRSA), which developed in vitro resistance to teicoplanin (MICs 16–32 mg/L).

The first patient was a 34-year-old man who presented with a 3 year history of lower back pain due to spondylolitic spondylolisthesis with degenerative changes. He underwent surgery with spinal instrumentation but developed a post-operative wound infection. Tissue and swab . . . [Full Text of this Article]

Acknowledgements

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
J. Cepeda, S. Hayman, T. Whitehouse, C. C. Kibbler, D. Livermore, M. Singer, and A. P. R. Wilson
Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unit
J. Antimicrob. Chemother., September 1, 2003; 52(3): 533 - 534.
[Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. L. Embleton, S. P. Nair, B. D. Cookson, and M. Wilson
Selective lethal photosensitization of methicillin-resistant Staphylococcus aureus using an IgG-tin (IV) chlorin e6 conjugate
J. Antimicrob. Chemother., December 1, 2002; 50(6): 857 - 864.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
F. M. MacKenzie, P. Greig, D. Morrison, G. Edwards, and I. M. Gould
Identification and characterization of teicoplanin-intermediate Staphylococcus aureus blood culture isolates in NE Scotland
J. Antimicrob. Chemother., November 1, 2002; 50(5): 689 - 697.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
H. M. Aucken, M. Ganner, S. Murchan, B. D. Cookson, and A. P. Johnson
A new UK strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-17) resistant to multiple antibiotics
J. Antimicrob. Chemother., August 1, 2002; 50(2): 171 - 175.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. Weinbren and K. Struthers
Emergence of Staphylococcus aureus (MRSA) with reduced susceptibility to teicoplanin during therapy
J. Antimicrob. Chemother., August 1, 2002; 50(2): 306 - 307.
[Full Text] [PDF]